Nitric oxide plays a crucial role in the development/progression of nonalcoholic steatohepatitis in the Choline-Deficient, l-Amino Acid-defined diet-fed rat model

Alcoholism: Clinical and Experimental Research

Volumn 34, Issue SUPPL. 1, 2010, Pages

  Fujita, Koji ^a   Nozaki, Yuichi ^a   Yoneda, Masato ^a   Wada, Koichiro ^b   Takahashi, Hirokazu ^a   Kirikoshi, Hiroyuki ^a   Inamori, Masahiko ^a   Saito, Satoru ^a   Iwasaki, Tomoyuki ^a   Terauchi, Yasuo ^a   Maeyama, Shiro ^c   Nakajima, Atsushi ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c Kitakashiwa Rehabilitation Hospital   (Japan)

Author keywords

Inducible nitric Oxide synthase; NASH; Nitric oxide; Nitrotyrosine; Visceral adipose tissue

Indexed keywords

3 NITROTYROSINE; AMINO ACID; CHOLINE; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; NITRATE; NITRIC OXIDE; NITRITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; BLOOD LEVEL; CLINICAL FEATURE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE COURSE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTRAABDOMINAL FAT; LIVER; LIVER FIBROSIS; MALE; MESENTERY; METABOLITE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PORTAL VEIN BLOOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TISSUE LEVEL; WESTERN BLOTTING;

AMINO ACIDS; ANIMALS; BLOTTING, WESTERN; CHOLINE; CHOLINE DEFICIENCY; DIET; DISEASE MODELS, ANIMAL; FATTY LIVER; INTRA-ABDOMINAL FAT; LIVER; MALE; NITRATES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; OXIDATIVE STRESS; RATS; RATS, INBRED F344; RNA, MESSENGER; TYROSINE;

ANIMALIA; RATTUS;

EID: 74849101212     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/j.1530-0277.2008.00756.x     Document Type: Conference Paper

References (38)

1. Bacon BR, Farahvash MJ, Janney CG, Neuschwander-Tetri BA (1994) Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 107: 1103 1109.
2. Bedard S, Marcotte B, Marette A (1997) Cytokines modulate glucose transport in skeletal muscle by inducing the expression of inducible nitric oxide synthase. Biochem J 325: 487 493.
3. Begriche K, Igoudjil A, Pessayre D, Fromenty B (2006) Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. Mitochondrion 6 (1 1 28.
4. Chen Y, Hozawa S, Sawamura S, Sato S, Fukuyama N, Tsuji C, Mine T, Okada Y, Tanino R, Ogushi Y, Nakazawa H (2005) Deficiency of inducible nitric oxide synthase exacerbates hepatic fibrosis in mice fed high-fat diet. Biochem Biophys Res Commun 326: 45 51.
5. Choudhury J, Sanyal AJ (2005) Insulin resistance in NASH. Front Biosci 10: 1520 1533.
6. Dickhout JG, Hossain GS, Pozza LM, Zhou J, Lhotak S, Austin RC (2005) Peroxynitrite causes endoplasmic reticulum stress and apoptosis in human vascular endothelium: implications in atherogenesis. Arterioscler Thromb Vasc Biol 25 (12 2623 2629.
7. Fromenty B, Robin MA, Igoudjil A, Mansouri A, Pessayre D (2004) The ins and outs of mitochondrial dysfunction in NASH. Diabetes Metab 30 (2 121 138.
8. Guarner C, Soriano G, Tomas A, Bulbena O, Novella MT, Balanzo J, Vilardell F, Mourelle M, Moncada S (1993) Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia. Hepatology 18: 1139 1143.
9. Harrison SA, Kadakia S, Lang KA, Schenker S (2002) Nonalcoholic steatohepatitis: what we know in the new millennium. Am J Gastroenterol 97 (11 2714 2724.
10. Kapur S, Bedard S, Marcotte B, Cote CH, Marette A (1997) Expression of nitric oxide synthase in skeletal muscle: a novel role for nitric oxide as a modulator of insulin action. Diabetes 46: 1691 1700. (Pubitemid 27456399)
11. Kapur S, Marcotte B, Marette A (1999) Mechanism of adipose tissue iNOS induction in endotoxemia. Am J Physiol 276: E635 E641.
12. Kawaguchi K, Sakaida I, Tsuchiya M, Omori K, Takami T, Okita K (2004) Pioglitazone prevents hepatic steatosis, fibrosis, and enzyme-altered lesion in rat liver cirrhosis by a choline-deficient L-amino acid-defined diet. Biochem Biophys Res Commun 315 (1 187 195.
13. Kojima H, Sakurai S, Uemura M, Takekawa T, Morimoto H, Tamagawa Y, Fukui H (2005) Difference and similarity between non-alcoholic steatohepatitis and alcoholic liver disease. Alcohol Clin Exp Res 29: 259 263.
14. Koruk M, Taysi S, Savas MC, Yilmaz O, Akcay F, Karakok M (2004) Oxidative stress and enzymatic antioxidant status in patients with nonalcoholic steatohepatitis. Ann Clin Lab Sci 34 (1 57 62.
15. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680 685.
16. Laurent A, Nicco C, Tran Van Nhieu J, Borderie D, Chereau C, Conti F, Jaffray P, Soubrane O, Calmus Y, Weill B, Batteux F (2004) Pivotal role of superoxide anion and beneficial effect of antioxidant molecules in murine steatohepatitis. Hepatology 39 (5 1277 1285.
17. Lee SJ, Park H, Chang JH, Conklin JL (2006) Generation of nitric oxide in the opossum lower esophageal sphincter during physiological experimentation. Yonsei Med J 47 (2 223 229.
18. Leon X, Quer M, Orus C, del Prado Venegas M, Lopez M (2000) Distant metastases in head and neck cancer patients who achieved loco-regional control. Head Neck 22 (7 680 686.
19. Ludwig J, Viggiano TR, McGill DB, Oh BJ (1990) Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 55 (7 434 438.
20. Martin PY, Xu DL, Niederberger M, Weigert A, Tsai P, St John J, Gines P, Schrier RW (1996) Upregulation of endothelial constitutive NOS: a major role in the increased NO production in cirrhotic rats. Am J Physiol 270: 494 499.
21. McNaughton L, Puttagunta L, Martinez-Cuesta MA, Kneteman N, Mayers I, Moqbel R, Hamid Q, Radom MW (2002) Distribution of nitric oxide synthase in normal and cirrhotic human liver. Proc Natl Acad Sci USA 99: 17161 17166.
22. Morales-Ruiz M, Jimenez W, Perez-Sala D, Ros J, Leivas A, Lamas S, Rivera F, Arroyo V (1996) Increased nitric oxide synthase expression in arterial vessels of cirrhotic rats with ascites. Hepatology 24: 145 149.
23. Moshage H, Casini A, Lieber CS (1990) Acetaldehyde selectively stimulates collagen production in cultured rat liver fat-strong cells but not in hepatocytes. Hepatology 12: 511 518.
24. Nakae D (1999) Endogenous liver carcinogenesis in the rat. Pathol Int 49 (12 1028 1042.
25. Niederberger M, Gines P, Tsai P, Martin PY, Morris K, Weigert A, McMurtry I, Schrier RW (1995) Increased aortic cyclic guanosine monophosphate concentration in experimental cirrhosis in rats: evidence for a role of nitric oxide in the pathogenesis of arterial vasodilation in cirrhosis. Hepatology 21 (6 1625 1631.
26. Niu XL, Yang X, Hoshiai K, Tanaka K, Sawamura S, Koga Y, Nakazawa H (2001) Inducible nitric oxide synthase deficiency does not affect the susceptibility of mice to atherosclerosis but increases collagen content in lesions. Circulation 103: 1115 1120.
27. Okura M, Hiranuma T, Adachi T, Ogura T, Yoshioka H, Hayashida Y, Kogo M, Matsuya T (1998) Induction chemotherapy is associated with an increase in the incidence of locoregional recurrence in patients with carcinoma of the oral cavity: results from a single institution. Cancer 82 (5 804 815.
28. Perez-Carreras M, Del Hoyo P, Martin MA, Rubio JC, Martin A, Castellano G, Colina F, Arenas J, Solis-Herruzo JA (2003) Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis. Hepatology 38 (4 999 1007.
29. Powell EE, Cooksley WG, Hanson R, Searle J, Halliday JW, Powell LW (1990) The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 11 (1 74 80.
30. Rennard SI, Berg R, Martin GR, Foidart JM, Robey PG (1980) Enzyme-linked immunoassay (ELISA) for connective tissue components. Anal Biochem 104 (1 205 214.
31. Sahai A, Malladi P, Pan X, Paul R, Melin-Aldana H, Green RM, Whitington PF (2004) Obese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: role of short-form leptin receptors and osteopontin. Am J Physiol Gastrointest Liver Physiol 287 (5 1035 1043.
32. Sakaide I, Okita K (2005) The role of oxidative stress in NASH and fatty liver model. Hepatol Res 33 (2 128 131.
33. Sanz-Cameno P, Medina J, Garcia-Buey L, Garcia-Sanchez A, Borque MJ, Martin-Vilchez S, Gamallo C, Jones EA, Moreno-Otero R (2002) Enhanced intrahepatic inducible nitric oxide synthase expression and nitrotyrosine accumulation in primary biliary cirrhosis and autoimmune hepatitis. J Hepatol 37 (6 723 729.
34. Shimabukuro M, Zhou YT, Levi M, Unger RH (1998) Fatty acid-induced βcell apoptosis: a link between obesity and diabetes. Proc Natl Acad Sci USA 95: 2498 2502.
35. Sieber CC, Lopez-Talavera JC, Groszmann RJ (1993) Role of nitric oxide in the in vitro splanchnic vascular hyporeactivity in ascitic cirrhotic rats. Gastroenterology 104 (6 1750 1754.
36. Takamatsu Y, Shimada K, Yamaguchi K, Kuroki S, Chijiiwa K, Tanaka M (2006) Inhibition of inducible nitric oxide synthase prevents hepatic, but not pulmonary, injury following ischemia-reperfusion of rat liver. Dig Dis Sci 51 (3 571 579.
37. Wedman J, Balm AJ, Hart AA, Loftus BM, Hilgers FJ, Gregor RT, van Zandwijk N, Zoetmulder FA (1996) Value of resection of pulmonary metastases in head and neck cancer patients. Head Neck 18 (4 311 316.
38. Wei CL, Hon WM, Lee KH, Khoo HE (2005) Temporal expression of hepatic inducible nitric oxide synthase in liver cirrhosis. World J Gastroenterol 11: 362 367.